Comparing Paclitaxel Plus Fluorouracil Versus Cisplatin Plus Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Cancer: A Randomized, Multicenter, Phase III Clinical Trial | Zendy

Yun Chen | Zendy; Jinjun Ye | Zendy; Zhengfei Zhu | Zendy; Weixin Zhao | Zendy; Jialiang Zhou | Zendy; Chaoyang Wu | Zendy; Huarong Tang | Zendy; Min Fan | Zendy; Ling Li | Zendy; Qin Lin | Zendy; Yi Xia | Zendy; Yunhai Li | Zendy; Jiancheng Li | Zendy; Huixun Jia | Zendy; Saiquan Lu | Zendy; Zhen Zhang | Zendy; Kuaile Zhao | Zendy

Open Access

Comparing Paclitaxel Plus Fluorouracil Versus Cisplatin Plus Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Cancer: A Randomized, Multicenter, Phase III Clinical Trial

Author(s) -

Yun Chen,

Jinjun Ye,

Zhengfei Zhu,

Weixin Zhao,

Jialiang Zhou,

Chaoyang Wu,

Huarong Tang,

Min Fan,

Ling Li,

Qin Lin,

Yi Xia,

Yunhai Li,

Jiancheng Li,

Huixun Jia,

Saiquan Lu,

Zhen Zhang,

Kuaile Zhao

Publication year - 2019

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.18.02122

Subject(s) - fluorouracil , medicine , regimen , cisplatin , paclitaxel , chemotherapy , esophageal cancer , chemoradiotherapy , mucositis , oncology , surgery , gastroenterology , cancer

This trial aimed to assess the efficacy and safety of the paclitaxel plus fluorouracil regimen versus the cisplatin plus fluorouracil regimen in definitive concurrent chemoradiotherapy (dCRT) in patients with locally advanced esophageal squamous cell carcinoma (ESCC).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research